Trial intelligence / Profile preview

Effects of betahistine on central vestibular compensation in acute unilateral vestibular failure

DRKS00005039Phase 3Terminated

Sponsor
LMU Klinikum
Start
Aug 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in vestibular neuritis and Acute unilateral vestibular failure (AUVF) comparing Betahistine with Placebo (2 arms). Started Aug 2013; status: terminated.

02

Drugs

betahistine
03

Conditions

vestibular neuritisAcute unilateral vestibular failure (AUVF)

Beyond the preview

Go deeper on DRKS00005039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00005039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call